Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Core Points - Safety Shot, Inc. has received a 180-calendar day extension from Nasdaq to regain compliance with the minimum bid price requirement, now due by December 29, 2025 [1][4] - The company meets all other Nasdaq listing requirements except for the bid price, and has expressed intention to address this deficiency during the compliance period [2] - The company's common stock will continue to trade on Nasdaq under the ticker symbol "SHOT" without immediate effect from this notification [3] Company Strategy - The CEO of Safety Shot has indicated that the Board of Directors has approved several strategic options to meet the bid price requirement [4] - The company aims to maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days during the compliance period to regain compliance [4] - If compliance is not achieved by the deadline, the company may appeal any delisting decision to a Nasdaq Hearings Panel [4] Product Information - Safety Shot, Inc. specializes in wellness and dietary supplements, with its flagship product, Sure Shot, designed to lower blood alcohol content while enhancing clarity, energy, and mood [5]